United States Diabetes Care Devices Market Insight
Published: 30 May 2026 | Report Format: Electronic (PDF)
market for diabetes treatment devices in the United States is experiencing significant growth in terms of health technologies at an estimated CAGR of about 8.6%. This growth is mainly attributed to factors such as the increase in cases of diabetes, uptake of CGM, and demand for insulin pumps.
U.S. Diabetes Care Devices Market Insights Forecasts to 2035
- The US Diabetes Care Devices Market Size Was Estimated at USD 18.6 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.6% from 2025 to 2035
- The US Diabetes Care Devices Market Size is Expected to Reach USD 42.5 Billion by 2035
Notable Insights for U.S. Diabetes Care Devices Market
- Continuous glucose monitoring (CGM) devices accounted for nearly 46% of the United States diabetes care devices market in 2025.
- According to the device segment of the market, insulin delivery devices represented approximately 38% of total market share due to rising utilization of insulin pumps, smart insulin pens, and automated insulin management systems among diabetic patients across the United States.
- The United States government allocated investments exceeding USD 14.8 billion between 2024 and 2026 toward diabetes prevention programs, digital healthcare modernization, chronic disease management infrastructure, and advanced medical technology initiatives supporting diabetes care innovation nationwide.
- Connected diabetes management platform adoption increased by approximately 19% in 2025 due to expanding deployment of smartphone-integrated glucose monitoring systems, AI-powered insulin dosing solutions, and cloud-based patient monitoring technologies.
Download the eBook (ToC)
Why Buy This Report
- Gather highly specific and strategic information about the diabetes care devices market in the United States, including developments in continuous glucose monitoring systems, wearable insulin delivery technologies, AI-powered diabetes management platforms, remote patient monitoring solutions, and digital healthcare ecosystems transforming chronic disease management nationwide.
- Learn about changes taking place within the U.S. healthcare ecosystem due to telehealth expansion, personalized diabetes treatment strategies, connected healthcare technologies, smart wearable devices, and AI-enabled chronic disease analytics systems.
- Discover emerging opportunities for investment arising from developments in closed-loop insulin delivery systems, wearable biosensors, digital diabetes therapeutics, smart insulin pens, and next-generation remote healthcare infrastructure.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Diabetes Care Devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Diabetes Care Devices Market
- Abbott Laboratories
- Dexcom, Inc.
- Medtronic plc
- Insulet Corporation
- Becton, Dickinson and Company
- Tandem Diabetes Care, Inc.
- Roche Diabetes Care
- Ascensia Diabetes Care Holdings AG
- Others
Recent Developments:
- In March 2026, Abbott Laboratories expanded investments exceeding USD 780 million toward advanced continuous glucose monitoring technologies, AI-powered diabetes analytics platforms, and wearable healthcare infrastructure supporting next-generation diabetes management solutions across the United States.
- In November 2025, Dexcom, Inc. introduced upgraded real-time glucose monitoring systems integrated with predictive AI-based insulin management capabilities while investing approximately USD 420 million in connected diabetes care innovation programs nationwide.
Market Segmentation:
United States Diabetes Care Devices Market, By Device Type
- Blood Glucose Monitoring Devices
- Continuous Glucose Monitoring Devices
- Insulin Delivery Devices
- Smart Insulin Pens
- Others
United States Diabetes Care Devices Market, By Application
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Others
United States Diabetes Care Devices Market, By End User
- Hospitals
- Diagnostic Centers
- Homecare Settings
- Specialty Diabetes Clinics
- Others
Expert Views:
As per the industry forecasts, the US market for diabetes treatment devices is poised to experience significant growth in the long term. The reasons for this are the high prevalence rate of diabetes, widespread use of wearables in health care, and growing demand for personalized solutions for chronic diseases. The growing use of continuous glucose monitoring, AI-powered insulin delivery, and telemedicine is expected to fuel demand.
Author: Sanket and Pranali By Spherical Insights and Consulting